Federal judges rule that President Donald Trump can't direct the government to stop funding grotesque transgender "medicine." ...

Relugolix plus the two hormonal drugs are also approved in the US as Myfembree for uterine fibroids, where the GnRH antagonist is also sold on its own as Orgovyx for prostate cancer. Pfizer agreed ...

The global Assisted Reproductive Technology Market was valued at $25.1 billion in 2022 and is expected to grow significantly, ...

Sex hormones have a profound impact on the brain, affecting disorders like stroke, epilepsy, and Alzheimer’s. A new review ...

America’s FDA leadership has been making decisions based on ideology, not drug safety. It's time for a change of priorities.

Reproductive steroids are powerful hormones that play a key role in the growth and development of our bodies, especially during puberty.

Examples of "chemical and surgical mutilation" listed in the order include puberty blockers, including "GnRH agonists and other interventions" that "delay the onset or progression of normally timed ...

Myfembree combines relugolix – a small molecule, GnRH receptor antagonist – with two hormonal drugs (oestradiol and norethindrone acetate) and works by reducing the release of oestrogen and ...

Have you ever struggled with heavy periods, constant fatigue, or unexplained abdominal discomfort? For many women, these ...

Nonsteroidal antiinflammatory drugs—These kinds of medications include ... releasing hormone agonists (sometimes called GnRH agonists), danazol, and antifibrinolytic medications.

Briefly, the long-acting GnRH-agonist triptorelin (Diphereline ... by grants from the Yunnan Provincial Reproductive and Obstetrics and Gynecology Clinical Medicine Center (zx2019-01-01), Open Project ...